These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19109231)

  • 1. The temporal profile of the anti-PF4/heparin immune response.
    Greinacher A; Kohlmann T; Strobel U; Sheppard JA; Warkentin TE
    Blood; 2009 May; 113(20):4970-6. PubMed ID: 19109231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the immune response in heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
    Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
    Greinacher A; Juhl D; Strobel U; Wessel A; Lubenow N; Selleng K; Eichler P; Warkentin TE
    J Thromb Haemost; 2007 Aug; 5(8):1666-73. PubMed ID: 17488345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
    Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
    J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
    Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
    J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
    J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.
    Althaus K; Strobel U; Warkentin TE; Greinacher A
    Thromb Res; 2011 Sep; 128(3):256-60. PubMed ID: 21620439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
    Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
    Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
    J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.
    Eekels JJM; Althaus K; Bakchoul T; Kroll H; Kiefel V; Nazy I; Lee LS; Sachs U; Warkentin TE; Greinacher A
    J Thromb Haemost; 2019 Mar; 17(3):525-531. PubMed ID: 30640980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of heparin-induced antibodies in correlation with the result of the flow cytometric functional assay in the patients with suspected HIT.
    Maličev E; Maček Kvanka M; Klemenc P; Rožman P
    J Clin Pathol; 2017 Dec; 70(12):1084-1087. PubMed ID: 28903994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.